Pancreatic Cancer Research

ResearcherUniversity of LiègeActive in the last 2 years

Akeila Bellahcène

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9154-7631; OpenAlex author ID A5051999724, A5107834343. Sources: OpenAlex.

Their work

Papers
11 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
22
Papers, trials and grants by year

2018: 1 paper · 2019: 2 papers · 2020: none · 2021: none · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper · 2025: 3 papers · 2026: 1 paper

Papers 11

  1. Myoferlin at the crossroad of vesicle trafficking and mitochondrial function: implications for pancreatic cancer progression and stromal reprogramming. Co-author DOI 10.1042/bst20260427↗
  2. Focal adhesion assembly and cell migration require myoferlin in PDAC cell lines. Co-author DOI 10.1038/s41598-025-27134-2↗
  3. Targeting myoferlin in ER/Golgi vesicle trafficking reprograms pancreatic cancer-associated fibroblasts. Co-author DOI 10.1038/s44318-025-00570-6↗
  4. Glycation Stress–Driven Transcriptomic Signature Predicts Survival Benefit from Adjuvant Gemcitabine in Resectable Pancreatic Cancer Co-author DOI 10.1101/2025.07.07.663493↗
  5. Identification of myoferlin as a mitochondria-associated membranes component required for calcium signaling in PDAC cell lines. Co-author DOI 10.1186/s12964-024-01514-z↗
  6. Resistance to Gemcitabine in Pancreatic Cancer Is Connected to Methylglyoxal Stress and Heat Shock Response. Last author DOI 10.3390/cells12101414↗
  7. Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells. Co-author DOI 10.1016/j.redox.2022.102324↗
  8. Cancer-Associated Fibroblast Diversity Shapes Tumor Metabolism in Pancreatic Cancer. Co-author DOI 10.3390/cancers15010061↗
  9. Transforming growth factor beta-induced, an extracellular matrix interacting protein, enhances glycolysis and promotes pancreatic cancer cell migration. Co-author DOI 10.1002/ijc.32247↗
  10. Myoferlin Contributes to the Metastatic Phenotype of Pancreatic Cancer Cells by Enhancing Their Migratory Capacity through the Control of Oxidative Phosphoryla… Co-author DOI 10.3390/cancers11060853↗
  11. Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness. Co-author DOI 10.1038/s41388-018-0287-z↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Olivier Peulen · 10 shared papers, 2018–2026 · strength 1.71
  2. Raphaël Peiffer · 8 shared papers, 2018–2026 · strength 1.54
  3. Gilles Rademaker · 7 shared papers, 2018–2026 · strength 1.17
  4. Rebekah Crake · 4 shared papers, 2022–2025 · strength 0.74
  5. Charlotte Gullo · 3 shared papers, 2022–2025 · strength 0.62
  6. Sandy Anania · 3 shared papers, 2019–2024 · strength 0.44
  7. Oier Azurmendi Senar · 2 shared papers, 2023–2025 · strength 0.35
  8. Tatjana Arsenijevic · 2 shared papers, 2023–2025 · strength 0.35
  9. Vincent Castronovo · 3 shared papers, 2018–2022 · strength 0.28
  10. Brunella Costanza · 3 shared papers, 2018–2019 · strength 0.24
  11. Atsushi Masamune · 1 shared paper, 2025 · strength 0.21
  12. Jean-Luc Van-Laethem · 1 shared paper, 2025 · strength 0.20
  13. Julie Navez · 1 shared paper, 2025 · strength 0.20
  14. Thierry Conroy · 1 shared paper, 2025 · strength 0.20
  15. Pieter Demetter · 1 shared paper, 2025 · strength 0.20
  16. Rémy Nicolle · 1 shared paper, 2025 · strength 0.20
  17. Jerome F. Cros · 1 shared paper, 2025 · strength 0.20
  18. Christelle Bouchart · 1 shared paper, 2025 · strength 0.20
  19. Kosta Stosic · 1 shared paper, 2025 · strength 0.20
  20. Nicky D’Haene · 1 shared paper, 2023 · strength 0.15
  21. Jean‐Luc Van Laethem · 1 shared paper, 2023 · strength 0.15
  22. Andrei Turtoï · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.